Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Véronique Allaria-Lapierre"'
Autor:
Michel Lanteri-Minet, Joëlle Micallef, David Braunstein, Anne Donnet, Vincent Sciortino, Véronique Allaria-Lapierre, Vincent Pradel
Publikováno v:
Cephalalgia. 35:1172-1180
Introduction The objective of this study was to estimate and to characterize the actual patterns of triptan use and overuse in France using a drug reimbursement database. Methods We included all people covered by the French General Health Insurance S
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95394fab44a1ccfffdb80522ee94cd0f
https://doi.org/10.1177/0333102415570497
https://doi.org/10.1177/0333102415570497
Autor:
Gaëlle Martin, Véronique Allaria-Lapierre, Gaëtan Gentile, Joseline Zafack, Xavier Thirion, Sylvie Bonin-Guillaume, Joëlle Micallef, Vincent Sciortino
Publikováno v:
Therapies. 69:213-222
Resume Objectifs Notre etude identifie et caracterise les patients atteints de la maladie d’Alzheimer et maladies apparentees (MAMA) en decrivant leur exposition aux antipsychotiques et aux autres medicaments psychotropes. Methodes Cette etude a et
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::481b115bc13c09b53960b2ea6189ca2e
https://doi.org/10.2515/therapie/2014015
https://doi.org/10.2515/therapie/2014015
Autor:
Elisabeth Frauger, Joëlle Micallef, David Braunstein, Samira Djezzar, Xavier Thirion, Despina Amaslidou, Michel Spadari, Véronique Allaria-Lapierre, Vincent Sciortino
Publikováno v:
European Addiction Research
European Addiction Research, Karger, 2016, 22 (3), pp.119-126. ⟨10.1159/000439273⟩
European Addiction Research, 2016, 22 (3), pp.119-126. ⟨10.1159/000439273⟩
European Addiction Research, Karger, 2016, 22 (3), pp.119-126. ⟨10.1159/000439273⟩
European Addiction Research, 2016, 22 (3), pp.119-126. ⟨10.1159/000439273⟩
Purpose: The aim of this study was to describe the extent of methylphenidate (MPH) abuse and characterize its patterns by following several cases involving intravenous administration of crushed MPH tablets. Methods: First, a drug reimbursement databa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c789b73bb76261375c4fe99eb52adc64
https://hal.archives-ouvertes.fr/hal-01482640
https://hal.archives-ouvertes.fr/hal-01482640
Autor:
Véronique Allaria-Lapierre, Joëlle Micallef, Vincent Sciortino, Christelle Boczek, Patrick Reggio, Elisabeth Frauger
Publikováno v:
Therapies. 67:129-136
Resume Objectif Evaluer le taux de penetration national (TP) des generiques (GNR) de la buprenorphine haut dosage (BHD) en 2008 et son evolution depuis leur commercialisation (2006), tout en faisant un focus par dosage et par region. Methodes Etude r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b7cc51a682b15844bb63755718c6fc8c
https://doi.org/10.2515/therapie/2012011
https://doi.org/10.2515/therapie/2012011
Publikováno v:
Pratiques et Organisation des Soins. 40:25-30
Objectif : Le Departement universitaire de medecine generale (DUMG) de la Faculte de medecine de Marseille a dispense six sessions de formation theorique « le medecin generaliste et l’Assurance maladie » entre octobre 2003 et avril 2006, en parte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::272cb2268e735d0dad115a4b18a5baf7
https://doi.org/10.3917/pos.401.0025
https://doi.org/10.3917/pos.401.0025
Autor:
Thao Pham, Hervé Coudert, S. Trijau, François Natali, Véronique Allaria-Lapierre, Gaëlle de Lamotte, Pierre Lafforgue, Vincent Sciortino, Vincent Pradel
Publikováno v:
RMD Open
RMD Open : Rheumatic & Musculoskeletal Diseases
RMD Open : Rheumatic & Musculoskeletal Diseases, 2016, 2 (2), pp.e000249. ⟨10.1136/rmdopen-2016-000249⟩
RMD Open : Rheumatic & Musculoskeletal Diseases
RMD Open : Rheumatic & Musculoskeletal Diseases, 2016, 2 (2), pp.e000249. ⟨10.1136/rmdopen-2016-000249⟩
Introduction Long-term glucocorticoid therapy is the leading cause of secondary osteoporosis. The management of glucocorticoid-induced osteoporosis (GIOP) seems to be inadequate in many European countries. Objective To evaluate the rate of screening
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dae6a3585905039a4f7ffec54f85f2f6
https://doi.org/10.1136/rmdopen-2016-000249
https://doi.org/10.1136/rmdopen-2016-000249
Autor:
Sylvie, Bonin-Guillaume, Gaëlle, Martin, Joseline, Zafack, Gaétan, Gentile, Véronique, Allaria-Lapierre, Vincent, Sciortino, Xavier, Thirion, Joëlle, Micallef
Publikováno v:
Therapie. 69(3)
The aim of the study was to identify and to characterize patients with Alzheimer's disease or related dementia describing antipsychotics and other psychotropic expositions.The study was performed, in 2010, based on Provence-Alpes-Côte d'Azur region
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c023d3791649331daddd5e3003c9765f
https://pubmed.ncbi.nlm.nih.gov/24901289
https://pubmed.ncbi.nlm.nih.gov/24901289
Autor:
Christelle, Boczek, Elisabeth, Frauger, Joëlle, Micallef, Véronique, Allaria-Lapierre, Patrick, Reggio, Vincent, Sciortino
Publikováno v:
Therapie. 67(2)
To assess the national market penetration rate (PR) of generic high-dosage buprenorphine (HDB) in 2008 and its evolution since their marketing (2006), and making a point for each dosage and at regional level.Retrospective study over data using nation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7533e1cd38fb4f116ac59cba330ec2dc
https://pubmed.ncbi.nlm.nih.gov/22850099
https://pubmed.ncbi.nlm.nih.gov/22850099